National Health (Export Restriction - Chief Executive Medicare) Guidelines 2020 (Cth)

National Health (Export Restriction - Chief Executive Medicare) Guidelines 2020

I, Paul Creech, acting Chief Executive Medicare, make the following guidelines.

Dated 23 April 2020

Paul Creech Acting Chief Executive Medicare

1 Name This instrument is the National Health (Export Restriction - Chief Executive Medicare) Guidelines 2020.

2 Commencement This instrument commences on the first day on which they are no longer liable to be disallowed, or taken to be disallowed, under section 42 of the Legislation Act 2003.

3 Authority This instrument is made under section 99ZS(2) of the National Health Act 1953.

4 Definitions Note: A number of expressions used in this instrument are defined in section 99ZH of the Act, including the following: (a) Customs officer; (b) drug like substance; (c) prescription drug; and (d) prohibited export. In this instrument: Act means the National Health Act 1953. the agency means Services Australia. case officer means the Departmental employee dealing with a detained drug like substance. Departmental employee has the same meaning as in the Human Services (Medicare) Act 1973. detained substance means a drug like substance transferred to the Chief Executive Medicare under Division 4D of Part VII of the Act.

5 Purpose These Guidelines set out matters relating to the performance of functions and duties, and the exercise of powers, by the Chief Executive Medicare, or by Departmental employees, in relation to matters arising under Division 4D of Part VII of the Act.

6 Initial action (1) Following notification by a Customs officer that drug like substances have been detained under sections 99ZJ or 99ZK of the Act, a Departmental employee shall make arrangements at the first practicable opportunity for the transfer of the substance to an Exhibit Room pending examination.